ID   MESO-8T
AC   CVCL_RP23
DR   Wikidata; Q54905294
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 32.4 hours (Note=In 2% FCS), 38.6 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=26891694).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
RX   PubMed=26891694; DOI=10.1038/cdd.2015.165; PMCID=PMC4946883;
RA   Chernova T., Sun X.-M., Powley I.R., Galavotti S., Grosso S.,
RA   Murphy F.A., Miles G.J., Cresswell L., Antonov A.V., Bennett J.,
RA   Nakas A., Dinsdale D., Cain K., Bushell M., Willis A.E.,
RA   MacFarlane M.;
RT   "Molecular profiling reveals primary mesothelioma cell lines
RT   recapitulate human disease.";
RL   Cell Death Differ. 23:1152-1164(2016).
//